Amahitamo yo kuvura kuri kanseri ntoya y'ibihaha mubitaro byumye

Iki gitabo cyuzuye gishakisha ibinyuranye Amahitamo yo kuvura kuri kanseri ntoya y'ibihaha (SCLC) kuboneka mubitaro byambere. Tuzajya dusuzugura mu iterambere rirambye mu buvuzi, muganire ku byerekeranye n'ibyemezo byo kuvura, kandi tutange ubushishozi akamaro ko gushaka amakipe ya Oldcology. Wige ibijyanye na chimiorapy, imivugo, imiti yibasiwe, hamwe nubufasha bwo kwitondera gucunga SCLC.

Gusobanukirwa kanseri ntoya y'ibihaha

Kanseri ntoya y'ibihaha ni iki?

Kanseri ntoya ya selile (SCLC) ni ubwoko bwihuse kandi bwa kanseri y'ibihaha. Bikunze kwisuzumisha kurwego rwo hejuru, bigatuma hakiri kare no kuvura bidatinze. Ingirabuzimafatizo za kanseri zigaragara nto kandi zizengurutse munsi ya microscope, zitandukanya na kanseri idafite kanseri ntoya (NSCLC). SCLC yunvikana cyane na chimiotherapie, ikora ishingiro ryingamba nyinshi zifata.

Gutegura no gusuzuma bya SCLC

Gutanga neza Sclc ni ngombwa mugutegura uburyo bukwiye bwo kuvura. Ibi bikubiyemo ibizamini bitandukanye byo gusuzuma, harimo n'amashusho (CT Scan, scan), bronchoscopy, na biopsies, na biopsies kugirango basuzume urugero rwa kanseri. Gukoresha mubisanzwe bikurikirana SCLC mugihe gito-Icyiciro (cyafungiwe kuruhande rumwe rw'igituza) cyangwa icyiciro kinini (gikwirakwira kuruhande rumwe rw'igituza).

Amahitamo yo kuvura kuri kanseri ntoya ya selile

Chimiotherapie kuri sclc

Chimiotherapie ni urufatiro rwa kuvura kanseri nto. Ikoresha imiti ikomeye yo kwica selile za kanseri. Mubisanzwe byakoreshejwe kuri chimiotherapy kuri sclc akenshi bikubiyemo guhuza ibiyobyabwenge nka cisplatin na etoposide. Devinen yihariye hamwe na dosage biterwa nubuzima bwumuntu, icyiciro cya kanseri, nibindi bintu. Chimiotherapie cyane muri rusange ikoreshwa muburyo bugarukira-icyiciro cyagaciro na nini-stage sclc.

Imiti y'imirasire kuri SCLC

Umuvugizi w'imirasire ukoresha imirasire y'ingufu nyinshi ku ntego no gusenya ingirabuzimafatizo. Bikunze gukoreshwa muburyo bwo gufatanya na chimiotherapie, cyane cyane muburyo buke-stage Sclc. Umuvugizi w'imirasire urashobora kugabanuka, kugabanya ibimenyetso, no kunoza umubare urokoka iyo uhujwe na chimiotherapie. Ubwoko hamwe na dosage yubuvuzi bwimikorere biterwa numuntu numuntu kugiti cye.

ITANGAZAMAKURU RYA SCLC

Igitekerezo cyo kuvuza ibiyobyabwenge byibanda kuri molekile zihariye zigira uruhare mugutezimbere kwa karuvali no guteza imbere. Mugihe ubusanzwe bidafite akamaro muri SCLC ugereranije na NSCLC, ubushakashatsi bukomeje gushakisha imitsi mishya igamije iyi fomu ikaze ya kanseri. Kurugero, ibigeragezo bimwe na bimwe bishakisha ikoreshwa rya Imvotherapy afnent ahuza na chimiotherapie.

Gushyigikira kwita kuri SCLC

Ubuvuzi bushyigikiwe bugira uruhare runini mugucunga ingaruka za kuvura kanseri nto no kunoza ubuzima bwumurwayi. Ibi birashobora kuba bikubiyemo gucunga ububabare, gushyigikira imirire, no gucunga ibindi bimenyetso nkumunaniro hamwe nubuhumyi. Ubuvuzi bushyigikiwe ni ngombwa kugirango ukomeze kuba umurwayi mubuzima bwose muri gahunda yo kuvura.

Guhitamo ikigo gishinzwe kuvura kanseri ntoya ya selile

Guhitamo ibitaro bizwi hamwe nababitabazi babishoboye hamwe na gahunda yubuvuzi yuzuye ni ngombwa kugirango ikore neza kuvura kanseri nto. Tekereza ku bintu nk'ibitaro bya SCLC hamwe na SCLC, kubona ikoranabuhanga riteye imbere, kandi riboneka ku bigeragezo by'amavuriro. Ku barwayi bashaka uburyo bwo kwita cyane, the Shandong Baofa Kanseri Ikigo cyubushakashatsi itanga gahunda yuzuye ya kanseri. Bahariwe gutanga imyuga-yubuhanzi no gushyigikira abarwayi barwana na kanseri.

Ibigeragezo bya Clinical kuri SCLC

Uruhare mubigeragezo byubuvuzi burashobora gutanga uburyo bushya bwo kuvura no gutanga umusanzu mukuzamura imiti ya Sconc. Ibitaro byinshi nibigo byubushakashatsi bitanga ibigeragezo byubuvuzi kubarwayi bakoresheje SCLC. Muganire kubishoboka byo kuburanisha ababuranyi hamwe na oncologue yawe. Ibigeragezo by'amakuba bitanga amahirwe ku barwayi kwakira imiti no gutanga umusanzu mu iterambere ry'ejo hazaza mu kwita ku kanseri.

Prognose hamwe nijwi rirerire

Prognose ya kanseri ntoya ya selile Biratandukanye bitewe na stage yo gusuzuma, ubuzima bwumurwayi muri rusange, hamwe nigisubizo cyo kuvura. Mugihe SCLC ikunze kuba abanyamahane, iterambere ryo kuvura ryateje imbere ibisubizo kubarwayi benshi. Kwitaho bisanzwe no gukurikirana ni ngombwa nyuma yo kuvura no gucunga ibisubizo byose.

Kwamagana: Aya makuru ni agace gashinzwe kwigisha gusa kandi ntigomba gufatwa inama zubuvuzi. Buri gihe ujye ugisha inama inzobere mu buzima bwo gusuzuma no kuvura indwara iyo ari yo yose y'ubuvuzi.